UnitedHealth Group on July 16 reported second-quarter earnings of $6.38 per share, far exceeding analyst estimates of $4.85 per share and sending the stock of the country’s largest health insurer sharply upward in early-day trading.
UnitedHealth posted revenue of $112 billion and earnings from operations of $8 billion for the three-month period ending June 30. Based on the strong performance, the company raised its full-year guidance for adjusted net earnings between $19.50 and $20 per share, up from previous guidance of $18.25 per share.
The second-quarter earnings were also significantly improved from the $5.2 billion realized in the same quarter of 2025 due to stronger medical care performance from UnitedHealthcare and its subsidiary, Optum.
The Eden Prairie, Minnesota-based insurer is in the midst of a broad organizational turnaround enacted in 2025 to strengthen its operations, streamline management, enhance technology, and enhance customer and provider experiences. In May, UnitedHealth announced it was eliminating prior authorization requirements by 30 percent for a wide range of common medical services, with additional prior authorization reductions slated for later in the year in an effort to standardize industrywide medical processes.
“Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people,” UnitedHealth CEO Stephen Hemsley said in a July 16 statement.
Shares of the company were up 3.35 percent near midday trading but pared some of the gains and closed up 1.13 percent. The stock has been up more than 28 percent year to date.
In the first quarter, UnitedHealth shed its Optum UK business, netting $400 million, as it divested from international markets to streamline operations. The company also entered into an arrangement to buy back $2 billion of its common stock to bolster its share price. Through the end of June, UnitedHealth had repurchased $4 billion in shares of its common stock and said it expects to buy back another $1 billion by year-end.
UnitedHealth’s Optum businesses accounted for revenues of $65.7 billion and earnings from operations of $4 billion in the second quarter. Optum served more than 120 million customers in the quarter, while UnitedHealthcare served 48.5 million.
Hemsley, who led the company from 2006–2017 and returned to UnitedHealth Group in May 2025 to oversee its turnaround, said in an earnings call that the company’s strong second-quarter results are a sign that UnitedHealth’s initiatives are taking hold across its various businesses, which also include Optum Health, Optum Insight, Optum RX, and Optum Financial.
Optum Financial on July 2 completed its acquisition of Alegeus Technologies, boosting its benefits administration capabilities.
